Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells

Cancer Gene Therapy volume 12, pages 825–834 (2005)Cite this article

Abstract

Immunotherapy of squamous cell carcinoma (SCC) at an early stage of the disease increases the likelihood of success. We report a new vaccination strategy designed to prepare SCC vaccines from microgram amounts of tumor tissue, enabling the treatment of patients with minimal residual disease. The vaccine was prepared by transfer of sheared genomic DNA-fragments (25 kb) from KLN205 cells, an SCC cell line of DBA/2 mouse origin, into syngeneic bone marrow-derived mature dendritic cells (DCs). More than 90% of the transfected DCs took up DNA from the neoplasm and transferred genes were expressed as protein. The DCs expressed CD11c, CD11b, and the costimulatory molecules CD40, CD80 and CD86, characteristic of mature DCs. Syngeneic DBA/2J mice, highly susceptible to the growth of KLN205 cells, were injected intravenously (i.v.) with the transfected DCs, followed by a subcutaneous (s.c.) injection of the tumor cells. The strong immunogenic properties of the transfected cells were indicated by the finding that the survival of the tumor-bearing mice was prolonged (P<.001), relative to that of mice in various control groups. Enzyme-linked immuno spot (ELISPOT IFN-γ) assays revealed the activation of cell-mediated immunity directed toward the SCC in mice immunized with the transfected DCs. Two independent in vitro cytotoxicity assays indicated the presence of robust cell-mediated immunity directed toward the SCC in mice immunized with the transfected cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Herold-Mende C, Karcher J, Dyckhoff G, et al. Antitumor immunization of head and neck squamous cell carcinoma patients with a virus-modified autologous tumor cell vaccine. Adv Otorhinolaryngol. 2005;62:173–183.

    PubMed  Google Scholar 

  2. Karcher J, Dyckhoff G, Beckhove P, et al. Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells. Cancer Res. 2004;64:8057–8061.

    Article  CAS  Google Scholar 

  3. Hoffman TK, Bier H, Donnenberg AD, et al. p53 as an immunotherapeutic target in head and neck cancer. Adv Otorhinolaryngol. 2005;62:151–160.

    Google Scholar 

  4. Weise JB, Maune S, Gorogh T, et al. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC. Auris Nasus Larynx. 2004;31: 149–153.

    Article  Google Scholar 

  5. Boon T, Van den Eynde B . Tumour immunology. Curr Opin in Immunol. 2003;15:129–130.

    Article  CAS  Google Scholar 

  6. Couch M, Saunders JK, O'Malley Jr BW, et al. Genetically engineered tumor cell vaccine in a head and neck cancer model. Laryngoscope. 2003;113:552–556.

    Article  Google Scholar 

  7. Kimura Y, Mizuno H, Satake K, et al. Effects of combined therapy with interleukin 2 and interleukin 12 gene-transfected tumor vaccine for head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:1181–1185.

    Article  Google Scholar 

  8. Devaraj K, Gillison ML, Wu TC . Development of HPV vaccines for HPV-associated head and neck squamous cell carcinoma. Crit Rev Oral Biol Med. 2003;14:345–362.

    Article  Google Scholar 

  9. Strome SE, Voss S, Wilcox R, et al. Strategies for antigen loading of dendritic cells to enhance the anti tumor immune response. Cancer Res. 2002;262:1884–1889.

    Google Scholar 

  10. Avigan D . Dendritic cell-tumor fusion vaccines for renal cell carcinoma. Clin Cancer Res. 2004;10:6347S–6352S.

    Article  CAS  Google Scholar 

  11. O-Sullivan I, Ku G, Ertl HCJ, et al. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. Anticancer Res. 2002;22:613–622.

    Google Scholar 

  12. Son YI, Maillard RB, Watkins SC, et al. Dendritic cells pulsed with apoptotic squamous cell carcinoma have anti tumor effects when combined with Interleukin-2. Laryngoscope. 2001;111:1472–1478.

    Article  CAS  Google Scholar 

  13. Ridgway D . The first 1000 dendritic cell vaccines. Cancer Invest. 2003;21:969–970.

    Article  Google Scholar 

  14. Myers JN . The use of biological therapy in cancer of the head and neck. Curr Problems Cancer. 1999;23:106–134.

    Article  CAS  Google Scholar 

  15. Strome SE, Chen L . Costimulation-based immunotherapy for head and neck cancer. Curr Treat Options Oncol. 2004;5:27–33.

    Article  Google Scholar 

  16. Resser JR, Carbone DP . Immunotherapy of head and neck cancer. Curr Opin Oncol. 1998;10:226–232.

    Article  CAS  Google Scholar 

  17. Lowy I, Pellicer A, Jackson JF, et al. Isolation of transforming DNA: cloning the hamster aprt gene. Cell. 1980;22:817–823.

    Article  CAS  Google Scholar 

  18. Wigler M, Pellicer A, Silverstein S, et al. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc Natl Acad Sci USA. 1979;76:1373–1376.

    Article  CAS  Google Scholar 

  19. Hsu C, Kavathas P, Herzenberg LA . Cell surface antigens expressed on L cells transfected with whole DNA from non-expressing and expressing cells. Nature. 1984;312:68–69.

    Article  CAS  Google Scholar 

  20. Kavathas P, Herzenberg LA . Stable transformation of mouse LM cells (a transformed fibroblast cell line) for human membrane T-cell differentiation antigens, HLA and B2 microglobulin: Selection by fluorescence-activated cell sorting. Proc Natl Acad Sci USA. 1983;80:524–528.

    Article  CAS  Google Scholar 

  21. Son Y, Egawa S, Tatsumi T, et al. A novel bulk culture method for generating mature dendritic cells from mouse bone marrow cells. J Immunol Methods. 2002;262:145–157.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by NIDCR Grant Number 1 RO1 DEO13970-O1A2 awarded to Dr Cohen.

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, University of Illinois College of Medicine, Chicago, 60612, Illinois, USA

    InSug O-Sullivan, Lauren K Ng, Don M Martinez, Amla Chopra & Edward P Cohen

  2. College of Pharmacy, Chonnam National University, Gwangju, 500-757, Korea

    Tae S Kim

Authors
  1. InSug O-Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lauren K Ng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Don M Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tae S Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amla Chopra
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Edward P Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to InSug O-Sullivan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O-Sullivan, I., Ng, L., Martinez, D. et al. Immunity to squamous carcinoma in mice immunized with dendritic cells transfected with genomic DNA from squamous carcinoma cells. Cancer Gene Ther 12, 825–834 (2005). https://doi.org/10.1038/sj.cgt.7700847

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.cgt.7700847

Keywords

Search

Advanced search

Quick links